Valeant Pharmaceuticals International Inc (NYSE:VRX)

228.49
Delayed Data
As of Jul 02
 +0.25 / +0.11%
Today’s Change
106.00
Today|||52-Week Range
246.01
+59.66%
Year-to-Date

Today’s Trading

Previous close228.24
Today’s open228.57
Day’s range224.36 - 229.53
Volume981,188
Average volume (3 months)1,708,052
Market cap$78.0B
Dividend yield--
Data as of 07/02/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+33.21%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+43.22%
P/E ratio85.4
Price/Sales5.93
Price/Book14.38

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.11-0.22%
AZNAstraZeneca+0.77+1.19%
CELGCelgene+1.30+1.10%
LLYEli Lilly and Co+1.29+1.52%
Data as of 07/02/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$2.46
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers